483
Datong Tongxing Antibiotics Co., Ltd.Datong Tongxing Antibiotics Co., Ltd. – FDA 483, Jul 4, 2025
Record Details
An FDA inspection of Datong Tongxing Antibiotics Co., Ltd. in Datong, China, an API drug manufacturer, revealed significant deficiencies in their Batch Production Records. The firm failed to adequately prepare production and control records for API intermediate batches, specifically lacking detailed descriptions for raw material quantities and labeling steps. These issues indicate a failure to maintain proper documentation for drug manufacturing processes.
View Company Profile
ID · 1b7f6275-b93b-4e3c-b7bf-a83a08da9556
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.